Schedule 13G ownership disclosure
GW PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 36197T103
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 43,476,806
- Percent of class
- 11.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-20-000045
- Form type
- SC 13G
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Feb 14, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership